Skip to main content

Table 2 Results

From: Expression of thymidine phosphorylase in peripheral blood cells of breast cancer patients is not increased by paclitaxel

Week

Measurement

Results (TP ng/ml) (mean +/- SD; 95% CI; outliers)

1

1

299.24 ± 35.09; 95% CI 199.09 – 258.58;

283.42; 169.49

 

2

182.97 ± 56.18; 95% CI 136.00 – 229.93;

240.39; 93.80

 

3

246.77 ± 70.14; 95% CI 188.13 – 305.41;

350.41; 173.99

 

4

155.20 ± 72.11; 95% CI 94.92 – 215.49;

242.42; 49.57

 

5

170.66 ± 47.63; 95% CI 130.84 – 210.47;

232.71; 115.57

 

6

187.55 ± 67.24; 95% CI 131.33 – 243.76;

295.48; 79.59

 

7

200.79 ± 105.45; 95% CI 112.64 – 288.95;

369.96; 17.24

 

8

196.36 ± 139.83; 95% CI 79.46 – 313.27;

431.39; 4.74

6

1

233.98 ± 52.29; 95% CI 190.26 – 277.70;

297.52; 125.95

 

2

177.54 ± 76.06; 95% CI 113.95 – 241.13;

258.41; 50.44

 

3

179.14 ± 76.68; 95% CI 115.03 – 243.24;

273.87; 43.42

 

4

110.93 ± 66.80; 95% CI 55.08 – 166.77;

187.07; 20.76

 

5

183.81 ± 52.89; 95% CI 139.59 – 228.02;

228.32; 60.86

 

6

185.02 ± 70.87; 95% CI 125.77 – 244.27;

251.34; 43.74

 

7

232.50 ± 126.58; 95% CI 126.67 – 338.32;

371.45; 6.62

 

8

215.03 ± 90.78; 95% CI 139.13 – 290.92;

297.99; 7.56